+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-01-30Number of Pages: 102

Platelet Rich Plasma Market (By Types: Pure-Platelet Rich Plasma, Leukocyte-Platelet Rich Plasma and Leukocyte-Platelet Rich Fibrin; By Origin: Autologus, Allogenic and Homologus; By Applications: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery and Other Surgeries) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020


Platelet rich plasma (PRP) is a blood plasma derived product, which typically contains an elevated level of platelets and growth factors (at least four to eight times) than normal blood concentration. Increasing number of orthopedic surgeries and sports injuries, rising number of cosmetic surgeries, approval of new devices and discovery of new application areas and growing awareness amongst the global population are the prime factors driving the growth of global PRP market. According to the statistics provided by the International Society of Plastic and Aesthetic Surgeons (ISAPS), 11 million non-invasive cosmetic procedures were performed worldwide in 2013, including approximately 3.0 million dermal filler procedures. This extensive number of cosmetic surgeries performed is considered as one of the most prominent factor propelling the growth of the global PRP market during the forecast period from 2014 to 2020. Furthermore, increasing application areas such as erectile dysfunction and vampire facelift also support the market growth in the near future. However, high cost of the devices and therapy and threat of therapy failure are some of the factors restricting the market growth to some extent. 

P-PRP (Pure-PRP) segment was identified as the largest type of PRP in 2013. Extensive use of P-PRP for orthopedic diseases and rich content of platelets and growth factors are expected to support the leadership position of the market segment. On the other hand, higher number of growth factors that promote rapid healing of injuries is likely to accelerate the L-PRF segment in the near future. In addition, cost effective platelet derivative, rich content of stem cells and leukocytes and high efficiency to treat diseases such as tendons and ligament injuries and neurological diseases are the other key factors that support the growth of L-PRF segment.

On the basis of origin, autologus PRP accounted for the largest market share in 2013. Ease of production, cost-effectiveness and lowest threat of disease transfusion are some of prominent factors that contributed in the dominance of this market segment. However, allogenic PRP segment is anticipated to witness a strong growth rate during the forecast period owing to high concentration of growth factors coupled with reduced time of wound healing. 

Orthopedic surgery was the largest application segment in 2013. Increasing prevalence of orthopedic diseases and promotion of PRP technique by various sports personalities are some of the factors responsible for the dominance of this application segment in the global PRP market. PRP products are widely used in cosmetic surgeries to improve facial aesthetics, enhance the rate of injury healing and modify facial structure (vampire facelift treatment). In addition, cosmetic surgeries performed with the use of PRP products modify the facial aesthetics in a short period of time due to reduction in the healing time. Thus, owing to all the above mentioned factors cosmetic surgery application segment is likely to witness the highest growth rate during the forecast period from 2014 to 2020. 

Geographically, the platelet rich plasma market has been segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America accounted for the largest share in the global PRP market in 2013. The dominance of this region was majorly due to increasing prevalence of orthopedic diseases, growing cosmetic surgeries, approvals of various devices by the U.S. FDA and growing awareness among the patient population. However, Asia-Pacific is likely to witness the highest CAGR of more than 15.0% during the forecast period from 2014 to 2020. Rapidly increasing awareness about PRP products and expanding medical tourism are some of the major drivers of the PRP market in this region..

Major players having presence in the global PRP market include Harvest Technologies Corp., Biomet, Inc., Arthrex, Inc. and Arteriocyte Medical Systems, Inc. Other major players include Dr. PRP America, Cesca Therapeutics, Inc. and Regen Lab SA amongst others.

platelet-rich-plasma-market


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
              1.3.1.1 Secondary Research
              1.3.1.2 Primary Research
      1.3.2 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global PRP Market (2013 & 2020)
2.2 Global PRP Market, by Types, 2013 (USD Million)
2.3 Global PRP Market, by Origin, 2013 (USD Million)
2.4 Global PRP Market, by Applications, 2013 (USD Million)
2.5 Comparative Analysis: Global PRP Market, By Geography, 2013 & 2020 (Value %)

Chapter 3 Market Overview: Platelet Rich Plasma Market
3.1 Introduction and Market Definition
3.2 Event Impact Analysis
3.3 Market Dynamics
      3.3.1 Market Drivers
              3.3.1.1 Increase in prevalence of orthopedic diseases and sports injuries and thereby rise in number of surgeries fuel market growth
              3.3.1.2 Increasing cosmetic surgeries are likely to accelerate market growth
              3.3.1.3 Technological advancements and regulatory approvals for new devices are contributing to the growth of the global PRP market
               3.3.1.4 Increasing awareness about PRP products and devices in emerging economies would accelerate market growth
      3.3.2 Market Restraints
              3.3.2.1 High cost of PRP products and devices would restrain market growth
              3.3.2.2 Threat of therapy failure and disease transfer (in case of allogenic and homologus PRP) could offer the resistance to market growth
      3.3.3 Opportunities
              3.3.3.1 Development of technologically advanced devices and new application areas of PRP technology would open new avenues
3.4 Porters Five Force Analysis for the Global Platelet Rich Plasma (PRP) Market
      3.4.1 Bargaining Power of Suppliers
      3.4.2 Bargaining Power of Buyers
      3.4.3 Threat of Substitutes
      3.4.4 Threat of New Entrants
      3.4.5 Competitive Rivalry
3.5 Value Chain Analysis
3.6 Regulatory Scenario
3.7 Market Attractiveness Analysis: Global Platelet Rich Plasma (PRP) Market, by Geography, 2013
3.8 Competitive Landscape
      3.8.1 Global PRP Market Share Analysis, by Key Players, 2013 (Value %)

Chapter 4 Global Platelet-Rich Plasma Market, by Types
4.1 Overview
      4.1.1 Global PRP Market Revenue, by Types, 2012 – 2020 (USD Million)
4.2 Pure Platelet-Rich Plasma (P-PRP)
      4.2.1 Global Pure Platelet-Rich Plasma Market Revenue, 2012 – 2020, (USD Million)
4.3 Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
      4.3.1 Global Leukocyte-Rich Platelet Rich Plasma Market Revenue, 2012 – 2020, (USD Million)
4.4 Pure Platelet-Rich Fibrin (P-PRF)/ Leukocyte-Rich Platelet-Rich Fibrin (L-PRF)
      4.4.1 Global Leukocyte-Rich Platelet Rich Fibrin Market Revenue, 2012 – 2020, (USD Million)

Chapter 5 Global Platelet-Rich Plasma Market, by Origin
5.1 Overview
      5.1.1 Global PRP Market Revenue, by Origin, 2012 – 2020 (USD Million)
5.2 Autologus Platelet-Rich Plasma
      5.2.1 Global Autologus Platelet-Rich Plasma Market Revenue, 2012 – 2020, (USD Million)
5.3 Allogenic Platelet-Rich Plasma
      5.3.1 Global Allogenic Platelet-Rich Plasma Market Revenue, 2012 – 2020, (USD Million)
5.4 Homologus Platelet-Rich Plasma
      5.4.1 Global Homologus Platelet-Rich Plasma Market Revenue, 2012 – 2020, (USD Million)

Chapter 6 Global Platelet-Rich Plasma Market, by Applications
6.1 Overview
      6.1.1 Global PRP Market Revenue, by Applications, 2012 – 2020 (USD Million)
6.2 Orthopedic Surgery
      6.2.1 Global Orthopedic Surgery Market Revenue, 2012 – 2020, (USD Million)
6.3 Cosmetic Surgery
      6.3.1 Global Cosmetic Surgery Market Revenue, 2012 – 2020, (USD Million)
6.4 General Surgery
      6.4.1 Global General Surgery Market Revenue, 2012 – 2020, (USD Million)
6.5 Neurosurgery
      6.5.1 Global Neurosurgery Market Revenue, 2012 – 2020, (USD Million)
6.6 Other Surgeries (Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal)
      6.6.1 Global Other Surgeries Market Revenue, 2012 – 2020, (USD Million)

Chapter 7 Global Platelet Rich Plasma Market, by Geography
7.1 Overview
      7.1.1 Global PRP Market Revenue, by Geography, 2012 – 2020 (USD Million)
7.2 North America
      7.2.1 North America PRP Market, by Types, 2012 – 2020 (USD Million)
      7.2.2 North America PRP Market, by Origin, 2012 – 2020 (USD Million)
      7.2.3 North America PRP Market, by Applications, 2012 – 2020 (USD Million)
7.3 Europe
      7.3.1 Europe PRP Market, by Types, 2012 – 2020 (USD Million)
      7.3.2 Europe PRP Market, by Origin, 2012 – 2020 (USD Million)
      7.3.3 Europe PRP Market, by Applications, 2012 – 2020 (USD Million)
7.4 Asia-Pacific
      7.4.1 Asia-Pacific PRP Market, by Types, 2012 – 2020 (USD Million)
      7.4.2 Asia-Pacific PRP Market, by Origin, 2012 – 2020 (USD Million)
      7.4.3 Asia-Pacific PRP Market, by Applications, 2012 – 2020 (USD Million)
7.5 Rest of the World (RoW)
      7.5.1 RoW PRP Market, by Types, 2012 – 2020 (USD Million)
      7.5.2 RoW PRP Market, by Origin, 2012 – 2020 (USD Million)
      7.5.3 RoW PRP Market, by Applications, 2012 – 2020 (USD Million)

Chapter 8 Recommendations
8.1 Investment in emerging markets would open new avenues to accentuate market share
8.2 Development of new PRP devices and discovery of new application areas would fuel market growth
8.3 Commercialization and promotion of technologically advanced PRP devices to boost market growth

Chapter 9 Company Profiles
9.1 AdiStem Ltd.
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Arteriocyte Medical Systems, Inc.
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Arthrex, Inc.
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Biomet, Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Cesca Therapeutics, Inc.
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 Dr. PRP America LLC
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 EmCyte Corporation
      9.8.1 Company Overview      
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 Exactech, Inc.
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Harvest Technologies Corp.
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 Nuo Therapeutics, Inc. (Cytomedix, Inc.)
       9.11.1 Company Overview
       9.11.2 Financial Overview
       9.11.3 Product Portfolio
       9.11.4 Business Strategies
       9.11.5 Recent Developments
9.12 Regen Lab SA
       9.12.1 Company Overview
       9.12.2 Financial Overview
       9.12.3 Product Portfolio
       9.12.4 Business Strategies
       9.12.5 Recent Developments
9.13 Stryker Corporation
       9.13.1 Company Overview
       9.13.2 Financial Overview
       9.13.3 Product Portfolio
       9.13.4 Business Strategies
       9.13.5 Recent Developments


List of Figures

FIG. 1 Market Segmentation : Platelet Rich Plasma (PRP) Market
FIG. 2 Global PRP Market, by Types, 2013 (USD Million)
FIG. 3 Global PRP Market, by Origin, 2013 (USD Million)
FIG. 4 Global PRP Market, by Applications, 2013 (USD Million)
FIG. 5 Comparative Analysis: Global PRP Market, by Geography, 2013 & 2020 (Value %)
FIG. 6 Porter’s Five Forces Analysis: Global Platelet Rich Plasma (PRP) Market
FIG. 7 Value Chain Analysis for Platelet Rich Plasma Market
FIG. 8 Market Attractiveness Analysis: Global Platelet Rich Plasma Market, by Geography, 2013
FIG. 9 Global PRP Market Share Analysis, by Key Players, 2013 ( Value %)
FIG. 10 Global Pure Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
FIG. 11 Global Leukocyte- Rich Platelet Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
FIG. 12 Global Leukocyte- Rich Platelet Rich Fibrin Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 Global Autologus Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
FIG. 14 Global Allogenic Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
FIG. 15 Global Homologus Market Revenue, 2012 - 2020 (USD Million)
FIG. 16 Global Orthopedic Surgery Market Revenue, 2012 - 2020 (USD Million)
FIG. 17 Global Cosmetic Surgery Market Revenue, 2012 - 2020 (USD Million)
FIG. 18 Global General Surgery Market Revenue, 2012 - 2020 (USD Million)
FIG. 19 Global Neurosurgery Market Revenue, 2012 - 2020 (USD Million)
FIG. 20 Global Other Surgeries Market Revenue, 2012 - 2020 (USD Million)
FIG. 21 Biomet, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 22 Cesca Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 23 Exactech, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 24 Nuo Therapeutics, Inc. (Cytomedix, Inc.): Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million)


List of Tables

TABLE 1 Market Snapshot: Global PRP Market (2013 & 2020)
TABLE 2 Global PRP Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 3 Global PRP Market Revenue, by Origin, 2012 – 2020 (USD Million)
TABLE 4 Global PRP Market Revenue, by Applications, 2012 – 2020 (USD Million)
TABLE 5 Global PRP Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 6 North America PRP Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 7 North America PRP Market Revenue, by Origin, 2012 – 2020 (USD Million)
TABLE 8 North America PRP Market Revenue, by Applications, 2012 – 2020 (USD Million)
TABLE 9 Europe PRP Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 10 Europe PRP Market Revenue, by Origin, 2012 – 2020 (USD Million)
TABLE 11 Europe PRP Market Revenue, by Applications, 2012 – 2020 (USD Million)
TABLE 12 Asia-Pacific PRP Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 13 Asia-Pacific PRP Market Revenue, by Origin, 2012 – 2020 (USD Million)
TABLE 14 Asia-Pacific PRP Market Revenue, by Applications, 2012 – 2020 (USD Million)
TABLE 15 RoW PRP Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 16 RoW PRP Market Revenue, by Origin, 2012 – 2020 (USD Million)
TABLE 17 RoW PRP Market Revenue, by Applications, 2012 – 2020 (USD Million)


Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP globally. 

The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, various analyses such as event impact analysis, regulatory scenario and value chain analysis has also been provided. Event impact analysis encompasses the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics positively or negatively. Value chain analysis includes the study of major steps involved in the PRP devices preparation and distribution. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of PRP devices and products.

The global PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the global PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure PRF/leukocyte-rich PRF (L-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologus, homologus and allogenic PRP. Furthermore, on the basis of applications, the global PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2014 to 2020.

Geographically, the PRP market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2012 to 2020, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2014 to 2020.

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PRP market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global PRP market such as AdiStem Ltd., Arteriocyte Medical Systems, Inc., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., Dr. PRP America LLC., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.
Global Platelet Rich Plasma (PRP) Market is segmented as follows:
  • Global Platelet Rich Plasma (PRP) Market, by Types
    • Pure-Platelet Rich Plasma (P-PRP)
    • Leukocyte-Platelet Rich Plasma (L-PRP)
    • Leukocyte-Platelet Rich Fibrin (L-PRF)
  • Global Platelet Rich Plasma (PRP) Market, by Origin
    • Autologus
    • Homologus
    • Allogenic
  • Global Platelet Rich Plasma (PRP) Market, by Applications
    • Orthopedic Surgery
    • Cosmetic Surgery
    • General Surgery
    • Neurosurgery
    • Other Surgeries (Oral and Maxillofacial, Cardiothoracic, Periodontal and Urological)
  • Global Platelet Rich Plasma (PRP) Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)